University of California Cancer Consortium (UCCC) Molecular Tumor Board (MTB) |
Wednesday December 6, 2023 | 5:00 p.m. |
The second virtual session of the 2023–2024 UCCC MTB will be chaired by UC San Diego. Advance registration is required, and participation is limited to UC affiliates with valid UC email addresses.
|
Moores Cancer Center Holiday Celebration |
Join Moores research and clinical staff on Friday, December 15, 2023 to celebrate the holiday season with collegial evening of drinks, bites, music, and prizes. Please RSVP by Friday, December 8, 2023 to attend.
|
|
|
The Science Of . . . Live Podcast Recording with Dr. Georg Matt and Dr. Mateo Banegas |
November 30, 2023 | 4:00 p.m. to 6:00 p.m.
Moores Comer Commons
|
December 4, 2023 | 12:00 p.m.
Moores Comer Commons
|
December 6, 2023 | 12:00 p.m.
Moores Comer Commons
|
February 9 & 10, 2023
UC San Diego Park & Market
|
|
|
Moores Oncology K Award Grant Writing Workshop |
MD Anderson Cancer Center Grant Spotlight Series |
December 1, 2023 | 1:00 p.m. to 2:30 p.m. CST
|
Join Clifton (Dave) Fuller, MD, PhD, Guan-Yu Xiao, PhD, and Ivan H.C. Wu, PhD to learn about the K99/R00 mechanism and what reviewers look for in a successful application. Please contact Heather Brien (HMBrien@mdanderson.org) for more information. View Flyer for Details
|
NCI Intramural Continuing Umbrella of Research Experiences (iCURE) |
iCURE brings cohorts of students and scientists from diverse backgrounds into the multidisciplinary environment of National Cancer Institute (NCI) and supports their mentored research experiences. The program provides 2-year awards for post-baccalaureate and graduate students and 3-year awards for postdoctoral fellows. Applications will be accepted through December 6, 2023. Learn More and Apply
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Through this Notice of Funding Opportunity (NOFO), the NCI intends to support basic and translational research that will guide the development of a prophylactic or therapeutic KSHV vaccine. The U01 research projects funded through this NOFO will form a cooperative group: the KSHV Vaccine Development Consortium.
Deadline: December 23, 2023
|
In 2024, the ALSF Crazy 8 Initiative will target childhood cancer predisposition and prevention. This is an opportunity for an investigator to form a team of experts to leverage this award of $3–5 million over 4 years to improve the well-being of children with cancer and their families.
Deadline for Letter of Intent: January 4, 2024 at 8:00 p.m. ET
|
Through this NOFO, the NCI invites applications for investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically glucagon-like peptide (GLP)-1 or dual GLP-1/glucose dependent insulinotropic polypeptide (GIP)-1 receptor agonists, impact cancer risk. The agents are important because of not only their reported effects on thyroid, prostate, and other cancer risks, but also the generally more favorable efficacy and side effect profile, compared to other classes of incretin mimetics.
Deadline: January 5, 2024
|
|
|
| Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): Final analysis of an open-label, randomised, phase 2 trial |
Caitlin L. Costello, MD (Hematologic Malignancies)
|
|
|
|
|
Seryl-tRNA synthetase promotes translational readthrough by mRNA binding and involvement of the selenocysteine incorporation machinery |
Gene W. Yeo, PhD (Structural and Functional Genomics)
|
|
|
| Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study |
Rohit Loomba, MD (Cancer Control Program)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
61186372NSC2002: A Phase II, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients with Advanced or Metastatic Solid Tumors, Including EGFR-mutated Non-Small Cell Lung Cancer |
PI: Lyudmila Bazhenova, MD
NCT: NCT05498428
|
VBP201: A Long-term Follow-up Study of Patients Who Received VOR33 |
PI: Divya Koura, MD
NCT: NCT05309733
|
| |
EQUITY, DIVERSITY, AND INCLUSION (EDI) |
November is Native American Heritage Month |
Moores is proud to celebrate its unique culture by recognizing November as Native American Heritage Month, in alignment with a draft statement by the UCSD Intertribal Resource Center:
The UC San Diego community holds great respect for the land and the original people of the area where our campus is located. The university is built on the un-ceded territory of the Kumeyaay Nation. Today, the Kumeyaay people continue to maintain their political sovereignty and cultural traditions as vital members of the San Diego community. We acknowledge their tremendous contributions to our region and thank them for their stewardship.
The Intertribal Resource Center is working with Kumeyaay community members and the campus community to create an official statement for UC San Diego. Please visit https://itrc.ucsd.edu/ for more information and resources to help Moores celebrate you.
Moores Members are encouraged to contact EDI to recognize Native staff, researchers, faculty, or trainees (students) who have contributed to the community. Please share your nominees' names, emails, and two to three sentences about their contributions to Moores patient care and/or research at mcc_edi@health.ucsd.edu.
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT (COE) |
Cancer Health Equity Collaborative |
December 14, 2023 | 10:00 a.m. to 12:00 p.m. |
Join COE for the last CHEC workgroup meeting of the year, which will include (1) presentations from ACS CAN and ZERO Prostate Cancer and (2) an introduction to PFAS and cancer risks on behalf of the San Diego Fire Rescue Department. Capitalize on this opportunity to network and connect with community partners. Register Now
|
Prostate Cancer 101 Community Workshop |
December 7, 2023 | 5:30 p.m. to 6:30 p.m. |
Join COE and ZERO Prostate at the Jackie Robinson YMCA for their first ever workshop devoted to prostate cancer, which is open to the community and will provide information on prostate health, early detection, and access to resources. Empower yourself and your community. Free dinner and refreshments will be provided to all attendees.
Register Now
View Flyer
|
|
|
|
